NRG Oncology NRG-GY018 study demonstrates significantly improved progression free survival outcomes for women with advanced or recurrent endometrial cancer with the addition of pembrolizumab to…
According to a study recently published in the Journal of Clinical Oncology, South Carolina is experiencing one of the most significant increases in anal cancer…
The new drug has been shown to be faster and has fewer negative side effects compared to the current standard treatment. A team of researchers…
An international research team has discovered a potential new target for a drug that could prevent the deadly metastases responsible for 90% of cancer deaths….
Clinical study on nasopharyngeal cancer with an unexpected result. Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the…
A combination of three simple treatments may reduce invasive cancer risk by 61% among adults aged 70+. According to the National Cancer Institute, in 2020…
UC San Diego study detects tell-tale proteins released into circulation by cancer cells. A novel screening platform has flagged more than 95 percent of stage…
First comprehensive trial in patients with impaired immunity shows that mRNA-based COVID-19 vaccines are well tolerated. Spare a thought for patients with impaired immunity during…
A genetic signature of 27 microorganisms in stool defines the high-risk population for pancreatic ductal adenocarcinoma, the most common pancreatic cancer, and could be used…
Washington University to lead national clinical trial investigating therapy. Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its…
An experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer, according…
Higher coffee consumption is linked with a lower risk of endometrial cancer, a type of cancer that begins in the lining of uterus, according to…
First-of-its-kind meta-analysis published in The Lancet Oncology. Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is one of the common…
Data were collected before booster vaccine recommendation. The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had…
RNA molecule suppresses prostate tumor growth. Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While…
One in seven cancer patients around the world have missed out on potentially life-saving operations during COVID-19 lockdowns, a new study reveals. Planned cancer surgery…
A new drug has shown promise in slowing the regrowth of tumors among some bowel cancer patients, according to new findings of a major trial…
Study is first to report comparison between an oral SERD and a standard aromatase inhibitor. Findings Early results from a UCLA-led clinical trial found treating…
